Join
Live feed
·
INSIDERFilingvia Quantisnow
Phio Pharmaceuticals Corp. logo

Chairman, Pres. & CEO Bitterman Robert J was granted 400,000 shares, increasing direct ownership by 110% to 764,871 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
PHIO· Phio Pharmaceuticals Corp.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PHIO (Phio Pharmaceuticals Corp.) and more on Quantisnow.